Evidence map›Paper›PMID 25323328›Full record

ArticleLung2015

Smoking cessation intervention within the framework of a lung cancer screening program: preliminary results and clinical perspectives from the "Cosmos-II" Trial.

Lococo Filippo, Rosastella Principe, Alfredo Cesario, Giovanni Apolone, Francesco Carleo, Pasquale Ialongo, Giulia Veronesi, Giuseppe Cardillo

Abstract read
PubMed Publisher
In one paragraph

Article in Lung, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Molecular biomarkers in early stage lung cancer.Translational lung cancer research · 2021
    Review
  6. Lung cancer screening and smoking cessation efforts.Translational lung cancer research · 2021
    Review
  7. Review
  8. Patient-Physician Discussions on Lung Cancer Screening: A Missed Teachable Moment to Promote Smoking Cessation.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020
    Article
  9. Article
  10. Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2019
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lococo FilippoUnit of Thoracic Surgery, IRCCS-Arcispedale Santa Maria Nuova, vial Risorgimento n 80, 42121, Reggio Emilia, Italy, filippo_lococo@yahoo.it.
Rosastella Principe
Alfredo Cesario
Giovanni Apolone
Francesco Carleo
Pasquale Ialongo
Giulia Veronesi
Giuseppe Cardillo

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Data coming from the literature investigating the effectiveness and interaction between smoking cessation (SC) and lung cancer screening (LCScr) are still sparse and inconsistent. Herein, we report the preliminary results from the ongoing lung cancer screening trial ("Cosmos-II") focusing our analysis on the inter-relationship between the SC program and the LCScr.

Indexed as

Smoking CessationSmoking PreventionAgedEarly Detection of CancerFemaleHealth Knowledge, Attitudes, PracticeHumansLung NeoplasmsMaleMiddle AgedMotivationPatient ComplianceProgram EvaluationRecurrenceRetrospective StudiesRisk Factors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.